Lesson of the week - Spurious hyperglycaemia and icodextrin in peritoneal dialysis fluid

被引：21

作者：

Riley, SG ^{[1
]}

Chess, J ^{[1
]}

Donovan, KL ^{[1
]}

Williams, JD ^{[1
]}

机构：

[1] Univ Wales Hosp, Inst Nephrol, Cardiff CF14 4XN, S Glam, Wales

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2003年 / 327卷 / 7415期

关键词：

D O I：

10.1136/bmj.327.7415.608

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：608 / 609

页数：2

共 8 条

[1]

ANSELL D, 2000, UK RENAL REGISTRY RE

[2] What is the place of peritoneal dialysis in the integrated treatment of renal failure? [J].

Coles, GA ;

Williams, JD .

KIDNEY INTERNATIONAL, 1998, 54 (06) :2234-2240

[3] Metabolic and laboratory effects of icodextrin [J].

Gokal, R ;

Moberly, J ;

Lindholm, B ;

Mujais, S .

KIDNEY INTERNATIONAL, 2002, 62 :S62-S71

[4] Global burden of diabetes, 1995-2025 - Prevalence, numerical estimates, and projections [J].

King, H ;

Aubert, RE ;

Herman, WH .

DIABETES CARE, 1998, 21 (09) :1414-1431

[5] Important causes of hypoglycaemia in patients with diabetes on peritoneal dialysis [J].

Mehmet, S ;

Quan, G ;

Thomas, S ;

Goldsmith, D .

DIABETIC MEDICINE, 2001, 18 (08) :679-682

[6] End-stage renal failure in type 2 diabetes:: A medical catastrophe of worldwide dimensions [J].

Ritz, E ;

Rychlík, I ;

Locatelli, F ;

Halimi, S .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (05) :795-808

[7]

Wens R, 1998, PERITON DIALYSIS INT, V18, P603

[8]

Wilkie ME, 1997, PERITON DIALYSIS INT, V17, P84

← 1 →